Your browser doesn't support javascript.
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
Huang, Ying; Xie, Changming; Chen, Xiaoke; Hong, Qianhui; Huang, Hui.
  • Huang Y; Cardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518000, China.
  • Xie C; Cardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518000, China.
  • Chen X; Respiratory Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518000, China.
  • Hong Q; Shenzhen Foreign Language School, Shenzhen, 518000, China.
  • Huang H; Cardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518000, China. Electronic address: huanghui765@hotmail.com.
Pharmacol Res ; 159: 104959, 2020 09.
Article in English | MEDLINE | ID: covidwho-526486

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin Receptor Antagonists / Betacoronavirus Topics: Long Covid Limits: Humans Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2020 Document Type: Article Affiliation country: J.phrs.2020.104959

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin Receptor Antagonists / Betacoronavirus Topics: Long Covid Limits: Humans Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2020 Document Type: Article Affiliation country: J.phrs.2020.104959